KeyBanc, Morgan Stanley Slash Price Target On Colfax
Colfax Corp's (NYSE:CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer multiples. The analyst maintained an Overweight rating on CFX shares. Related: Colfax's Q4 Earnings Morgan Stanley also lowered its price target on Colfax to $41 (an…
Benzinga ·